ANTIPHOSPHOLIPID ANTIBODIES ASSOCIATED VASCULAR EVENTS ARE AN UNDERRECOGNIZED CAUSE OF MORBIDITY AND MORTALITY AFTER LIVER TRANSPLANTATION: BENEFIT OF PLASMAPHERESIS AND ANTICOAGULATION IN TRANSPLANTED PATIENTS WITH HIGH THROMBOTIC RISK Sofía Tejada; Walter González; Eduardo De Santibañes; Ignacio Lucero; Juan Carlos Bandi; Alejandra Villamil;

EVALUATION OF RESPONSE TO SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADEQUATE RESPONSE TO UDCA: A PILOT STUDY OF LIVER BIOPSIES FOLLOW UP Alejandra Villamil; Daniela de la Viña; Eduardo Mullen; Ignacio Lucero; Juan Carlos Bandi;

OP-8 SECOND LINE THERAPY IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND INADECUATE RESPONSE: ARE WE CHOOSING THE RIGHT TARGET POPULATION FOR CLINICALS TRIALS? Daniela De La Viña; Natalia Sobenko; Eduardo Mullen; Ignacio Lucero; Juan Carlos Bandi; Maria Alejandra Villamil;